Workflow
上海新阳(300236) - 2025 Q4 - 年度财报
2026-03-12 11:30
上海新阳半导体材料股份有限公司 2025 年年度报告全文 上海新阳半导体材料股份有限公司 2025 年年度报告 2026 年 3 月 13 日 1 上海新阳半导体材料股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律 责任。 公司负责人王溯、主管会计工作负责人周红晓及会计机构负责人(会计主 管人员)曾霞芸声明:保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本年度报告涉及的发展战略、经营计划及其他未来计划等前瞻性陈述, 均不构成公司对任何投资者及相关人士的实质承诺,投资者及相关人士应对 此保持足够的风险认识,并且应当理解计划、预测与承诺之间的差异。 本公司请投资者认真阅读本年度报告全文,并特别注意公司在本报告第 三节"管理层讨论与分析"之"十一、公司未来发展的展望"中"(三)公司 面临的风险因素和应对措施"部分,详细描述了公司经营中可能存在的风险 及应对措施,敬请投资者关注相关内容。 公司经本次董事 ...
天虹股份(002419) - 2025 Q4 - 年度财报
2026-03-12 11:30
天虹数科商业股份有限公司 2025 年度报告全文 天虹数科商业股份有限公司 RAINBOW DIGITAL COMMERCIAL CO., LTD. 2025 年度报告 2026 年 3 月 天虹数科商业股份有限公司 2025 年度报告全文 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完整,不存在虚 假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人肖章林、主管会计工作负责人陈卓及会计机构负责人(会计主管人员)左 幼琼声明:保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本年度报告涉及的公司未来发展展望、经营计划等前瞻性陈述,不构成公司对投资者 的实质承诺,投资者及相关人士均应当对此保持足够的风险认识,并且应当理解计划、预 测与承诺之间的差异。 公司已在本报告中详细描述了公司可能面对的风险因素,请查阅第三节管理层讨论与 分析中关于公司未来发展展望的内容,敬请注意投资风险。 公司经本次董事会审议通过的利润分配预案为:公司拟以权益分派实施时股权登记日 的总股本(剔除公司回购专用证券账户持有股份数量)为基数, ...
深南电路(002916) - 2025 Q4 - 年度财报
2026-03-12 11:25
深南电路股份有限公司 2025 年年度报告全文 深南电路股份有限公司 2025 年年度报告 2026 年 3 月 1 深南电路股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人杨之诚、主管会计工作负责人楼志勇及会计机构负责人(会计 主管人员)楼志勇声明:保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本年度报告涉及未来计划等前瞻性描述,不构成公司对投资者的实质承 诺,请投资者注意投资风险。 公司已在报告中描述可能存在的宏观经济波动风险、国际经贸摩擦风险、 市场竞争风险、进入新市场及开发新产品的风险、海外工厂运营风险、产能扩 张后的爬坡风险、原物料供应及价格波动风险、汇率风险,敬请查阅"第三节 管理层讨论与分析 十一、公司未来发展的展望(四)可能面临的风险和应对措 施" 部分内容。 公司经本次董事会审议通过的利润分配预案为:以利润分配方案未来实施 时股权登记日的股本总数为基数,向全体股 ...
宝丰能源(600989) - 2025 Q4 - 年度财报
2026-03-12 11:25
宁夏宝丰能源集团股份有限公司2025 年年度报告 公司代码:600989 公司简称:宝丰能源 宁夏宝丰能源集团股份有限公司 2025 年年度报告 1 / 246 宁夏宝丰能源集团股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性,不存在 虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 安永华明会计师事务所(特殊普通合伙)为本公司出具了标准无保留意见的审计报告。 四、公司负责人刘元管、主管会计工作负责人王东旭 及会计机构负责人(会计主管人员)王东 旭声明:保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司2025年末期利润分配方案为:以公司总股本7,333,360,000股扣除回购股份60,593,400股后 7,272,766,600股为基数,拟派发现金红利3,054,557,999.96元。其中中小股东每股派发现金红利 0.4921元(含税),大股东每股派发现金红利0.3906元(含税)。本年度不进行资本公积转增股本。 加上 ...
帝尔激光(300776) - 2025 Q4 - 年度业绩
2026-03-12 11:20
证券代码:300776 证券简称:帝尔激光 公告编号:2026-012 | 项目 | 本报告期 | 上年同期 | 增减变动幅度(%) | | --- | --- | --- | --- | | 营业总收入 | 203,310.35 | 201,435.15 | 0.93% | | 营业利润 | 57,086.97 | 59,374.41 | -3.85% | | 利润总额 | 58,245.98 | 59,369.72 | -1.89% | | 归属于上市公司股东的 净利润 | 51,922.33 | 52,761.13 | -1.59% | | 扣除非经常性损益后的 归属于上市公司股东的 | 47,477.97 | 49,165.13 | -3.43% | | 净利润 | | | | | 基本每股收益(元/股) | 1.91 | 1.94 | -1.55% | | 加权平均净资产收益率 (%) | 14.09% | 16.25% | -2.16% | | 项目 | 本报告期末 | 本报告期初 | 增减变动幅度(%) | | 总资产 | 665,303.45 | 662,077.60 | 0.49% | | ...
浦东金桥(600639) - 2025 Q4 - 年度业绩
2026-03-12 10:45
Financial Performance - Total operating revenue for 2025 reached RMB 5,964,911,229.67, a significant increase of 118.91% compared to RMB 2,724,786,282.83 in the previous year[4] - Net profit attributable to shareholders of the listed company was RMB 1,073,513,488.46, reflecting a growth of 7.14% from RMB 1,001,950,138.86 year-on-year[4] - The net profit excluding non-recurring gains and losses surged by 157.59% to RMB 929,360,276.13, up from RMB 360,785,108.57 in the previous year[4] - Basic earnings per share increased to RMB 0.9646, representing an 8.01% rise from RMB 0.8931[4] - The weighted average return on equity improved to 7.30%, an increase of 0.30 percentage points from 7.00%[4] Assets and Equity - Total assets at the end of the reporting period were RMB 47,468,108,622.57, a decrease of 2.40% from RMB 48,634,341,185.68 at the beginning of the period[4] - Shareholders' equity attributable to the listed company increased by 4.50% to RMB 15,178,179,750.89 from RMB 14,523,957,029.60[4] Revenue Drivers - The significant revenue growth was primarily driven by the recognition of sales income from the Biyun Liyue project amounting to RMB 4.068 billion[7] Cautionary Notes - The company cautioned that the financial data presented is preliminary and unaudited, and may differ from the final figures in the 2025 annual report[8] - Investors are advised to be aware of potential investment risks due to the preliminary nature of the reported financial data[8]
亚翔集成(603929) - 2025 Q4 - 年度财报
2026-03-12 10:40
亚翔系统集成科技(苏州)股份有限公司2025 年年度报告 公司代码:603929 公司简称:亚翔集成 亚翔系统集成科技(苏州)股份有限公司 2025 年年度报告 1 / 233 亚翔系统集成科技(苏州)股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性,不存在 虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、容诚会计师事务所(特殊普通合伙)为本公司出具了标准无保留意见的审计报告。 四、公司负责人姚祖骧、主管会计工作负责人王明君及会计机构负责人(会计主管人员)刘澍 声明:保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司董事会研究,拟以 2025年年末总股本 21,336万股为基数向全体股东每10股派发现金红利 16.50元(含税),分红总额为人民币352,044,000.00元,不送股,不转增股本,剩余未分配利润全 部结转以后年度分配。 截至报告期末,母公司存在未弥补亏损的相关情况及其对公司分红等事项的影响 □适用 √不适用 六、 ...
新媒股份(300770) - 2025 Q4 - 年度业绩
2026-03-12 10:35
Financial Performance - The total operating revenue for 2025 is expected to be ¥162,808.79 million, representing a year-on-year increase of 3.12%[5] - The net profit attributable to shareholders is projected to be ¥65,939.17 million, showing a slight increase of 0.23% compared to the previous year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses is estimated at ¥66,059.54 million, reflecting a decrease of 1.20% year-on-year[6] - The basic earnings per share is expected to be ¥2.89, an increase of 0.70% from ¥2.87 in the previous year[5] - The weighted average return on equity is projected to be 17.44%, up by 0.20% from 17.24% in the previous year[5] - Total assets at the end of the reporting period are expected to be ¥461,691.28 million, an increase of 2.20% from the beginning of the period[5] - The equity attributable to shareholders is projected to be ¥356,891.82 million, a decrease of 1.04% from the previous period[5] Strategic Goals - The company's strategic goal is to build a leading platform in the internet new media sector, with steady progress in various business operations[6] Financial Data Caution - The financial data presented is preliminary and subject to change upon final audit in the annual report[7] - Investors are advised to exercise caution and consider investment risks based on the preliminary financial data[7]
隆扬电子(301389) - 2025 Q4 - 年度业绩
2026-03-12 10:30
Financial Performance - The total operating revenue for 2025 reached CNY 504.25 million, a 75.31% increase compared to CNY 287.64 million in the same period last year [5]. - The net profit attributable to shareholders of the listed company was CNY 103.63 million, reflecting a 26.02% growth from CNY 82.23 million year-on-year [5]. - The basic earnings per share rose to CNY 0.37, up 27.59% from CNY 0.29 in the previous year [5]. - The net profit after deducting non-recurring gains and losses was CNY 91.38 million, an 18.01% increase from CNY 77.43 million year-on-year [5]. - The weighted average return on equity improved to 4.54%, an increase of 0.80% compared to 3.74% in the previous year [5]. Asset and Investment - Total assets increased by 37.00% to CNY 3,164.70 million from CNY 2,309.98 million at the beginning of the period, primarily due to the inclusion of acquired companies' assets [8]. - The net assets attributable to shareholders of the listed company were CNY 2,223.27 million, a slight increase of 0.25% from CNY 2,217.77 million at the beginning of the period [8]. - The company completed the acquisition of 51% of Weisi Shuanglian Technology Co., Ltd. in August 2025 and 70% of Suzhou Deyou New Materials Technology Co., Ltd. in September 2025, enhancing its core competitiveness in material R&D [7]. Strategic Focus - The company focused on the dual-driven development strategy of "electromagnetic shielding + copper foil," actively expanding customer resources in the electromagnetic shielding materials sector [7]. - The company emphasizes the importance of cautious investment decisions as the financial data is preliminary and unaudited [3].
艾德生物(300685) - 2025 Q4 - 年度业绩
2026-03-12 10:02
Financial Performance - Total revenue for 2025 reached CNY 119,767.04 million, an increase of 8.00% compared to CNY 110,894.87 million in the previous year[5] - Operating profit rose to CNY 41,765.74 million, marking a significant increase of 42.56% from CNY 29,297.80 million year-on-year[5] - Net profit attributable to shareholders was CNY 35,788.66 million, up 40.42% from CNY 25,486.34 million in the prior year[5] - The basic earnings per share increased to CNY 0.90, reflecting a growth of 40.63% compared to CNY 0.64 in the previous year[5] Assets and Equity - Total assets at the end of the reporting period were CNY 234,817.94 million, a 13.72% increase from CNY 206,480.17 million at the beginning of the period[7] - Shareholders' equity attributable to the company increased to CNY 203,638.10 million, a rise of 10.48% from CNY 184,326.48 million at the start of the period[7] - The company maintained a stable asset-liability structure, indicating a healthy financial status[7] Operational Efficiency - The increase in operating profit and net profit was attributed to organizational optimization and efficiency improvement measures[9] Strategic Initiatives - The company is advancing its international expansion and deepening partnerships with pharmaceutical companies to establish a precise diagnostic ecosystem[6] - The VAT rate for sales of testing reagents was adjusted to 13% starting January 1, 2025[5]